Oxford BioMedica PLC
LSE:OXB
Income Statement
Earnings Waterfall
Oxford BioMedica PLC
Revenue
|
119m
GBP
|
Cost of Revenue
|
-64m
GBP
|
Gross Profit
|
55m
GBP
|
Operating Expenses
|
-138.7m
GBP
|
Operating Income
|
-83.7m
GBP
|
Other Expenses
|
22m
GBP
|
Net Income
|
-61.6m
GBP
|
Income Statement
Oxford BioMedica PLC
Jun-2003 | Dec-2003 | Jun-2004 | Dec-2004 | Jun-2005 | Dec-2005 | Jun-2006 | Dec-2006 | Jun-2007 | Dec-2007 | Jun-2008 | Dec-2008 | Jun-2009 | Dec-2009 | Jun-2010 | Dec-2010 | Jun-2011 | Dec-2011 | Jun-2012 | Dec-2012 | Jun-2013 | Dec-2013 | Jun-2014 | Dec-2014 | Jun-2015 | Dec-2015 | Jun-2016 | Dec-2016 | Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
+236%
|
1
+49%
|
1
-9%
|
0
-12%
|
1
+86%
|
1
-2%
|
1
-5%
|
3
+241%
|
7
+179%
|
19
+157%
|
18
-1%
|
19
+3%
|
19
+1%
|
11
-45%
|
11
+6%
|
11
-4%
|
8
-28%
|
7
-7%
|
8
+8%
|
5
-30%
|
5
-1%
|
8
+49%
|
14
+70%
|
13
-3%
|
16
+20%
|
24
+51%
|
28
+16%
|
31
+12%
|
38
+21%
|
57
+52%
|
67
+17%
|
64
-5%
|
64
+1%
|
66
+3%
|
88
+33%
|
135
+54%
|
143
+6%
|
126
-12%
|
140
+11%
|
119
-15%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
1
|
1
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
(3)
|
(4)
|
(5)
|
(6)
|
(8)
|
(12)
|
(15)
|
(18)
|
(21)
|
(23)
|
(24)
|
(36)
|
(34)
|
(42)
|
(70)
|
(60)
|
(50)
|
(71)
|
(64)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
+262%
|
2
+225%
|
7
+174%
|
17
+153%
|
17
0%
|
18
+4%
|
19
+5%
|
12
-36%
|
12
-2%
|
10
-13%
|
7
-30%
|
6
-10%
|
7
+10%
|
5
-27%
|
4
-18%
|
5
+20%
|
9
+80%
|
8
-9%
|
10
+21%
|
16
+56%
|
16
+2%
|
16
+0%
|
19
+20%
|
37
+91%
|
44
+20%
|
39
-11%
|
28
-28%
|
32
+12%
|
46
+46%
|
65
+42%
|
83
+27%
|
76
-8%
|
69
-9%
|
55
-21%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(14)
|
(13)
|
(13)
|
(11)
|
(11)
|
(12)
|
(16)
|
(22)
|
(24)
|
(26)
|
(29)
|
(26)
|
(22)
|
(21)
|
(20)
|
(20)
|
(21)
|
(18)
|
(18)
|
(18)
|
(17)
|
(17)
|
(17)
|
(20)
|
(22)
|
(24)
|
(28)
|
(27)
|
(25)
|
(27)
|
(31)
|
(36)
|
(46)
|
(41)
|
(44)
|
(51)
|
(45)
|
(62)
|
(94)
|
(121)
|
(139)
|
|
Selling, General & Administrative |
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(5)
|
(4)
|
(4)
|
(6)
|
(5)
|
(4)
|
(4)
|
(4)
|
(5)
|
(4)
|
(3)
|
(3)
|
(3)
|
(4)
|
(5)
|
(7)
|
(8)
|
(6)
|
(5)
|
(7)
|
(7)
|
(7)
|
(9)
|
(12)
|
(13)
|
(11)
|
(13)
|
(15)
|
(26)
|
(28)
|
(25)
|
|
Research & Development |
(11)
|
(11)
|
(11)
|
(9)
|
(9)
|
(9)
|
(14)
|
(20)
|
(21)
|
(22)
|
(24)
|
(22)
|
(17)
|
(15)
|
(15)
|
(16)
|
(17)
|
(15)
|
(13)
|
(14)
|
(14)
|
(14)
|
(14)
|
(17)
|
(19)
|
(20)
|
(24)
|
(24)
|
(22)
|
(21)
|
(25)
|
(30)
|
(33)
|
(23)
|
(20)
|
(30)
|
(29)
|
(40)
|
(53)
|
(61)
|
(65)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Operating Expenses |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
3
|
3
|
3
|
2
|
2
|
2
|
1
|
(3)
|
(6)
|
(12)
|
(10)
|
(4)
|
(6)
|
(15)
|
(32)
|
(49)
|
|
Operating Income |
(14)
N/A
|
(13)
+9%
|
(12)
+2%
|
(11)
+12%
|
(11)
+1%
|
(11)
-3%
|
(15)
-38%
|
(21)
-36%
|
(22)
-3%
|
(19)
+10%
|
(12)
+41%
|
(9)
+21%
|
(4)
+58%
|
(2)
+43%
|
(8)
-276%
|
(8)
+1%
|
(10)
-28%
|
(11)
-10%
|
(11)
+1%
|
(10)
+6%
|
(11)
-9%
|
(13)
-12%
|
(12)
+10%
|
(11)
+8%
|
(13)
-27%
|
(14)
-5%
|
(13)
+9%
|
(11)
+11%
|
(9)
+21%
|
(8)
+10%
|
6
N/A
|
8
+34%
|
(6)
N/A
|
(13)
-98%
|
(13)
-1%
|
(5)
+62%
|
20
N/A
|
21
+5%
|
(18)
N/A
|
(52)
-189%
|
(84)
-62%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(3)
|
(8)
|
(9)
|
(5)
|
(4)
|
(7)
|
(3)
|
(6)
|
(8)
|
(2)
|
(2)
|
(1)
|
(1)
|
(9)
|
(16)
|
(9)
|
|
Non-Reccuring Items |
0
|
0
|
(2)
|
(2)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(5)
|
(9)
|
(4)
|
0
|
(4)
|
(7)
|
(3)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
21
|
22
|
|
Total Other Income |
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
|
Pre-Tax Income |
(13)
N/A
|
(12)
+9%
|
(13)
-9%
|
(11)
+13%
|
(10)
+13%
|
(10)
-5%
|
(14)
-37%
|
(19)
-38%
|
(20)
-5%
|
(18)
+13%
|
(9)
+47%
|
(12)
-28%
|
(11)
+6%
|
(5)
+55%
|
(7)
-45%
|
(12)
-60%
|
(17)
-46%
|
(14)
+17%
|
(11)
+23%
|
(10)
+6%
|
(11)
-10%
|
(13)
-13%
|
(12)
+8%
|
(11)
+8%
|
(14)
-28%
|
(17)
-23%
|
(20)
-20%
|
(20)
+0%
|
(14)
+30%
|
(12)
+17%
|
(1)
+94%
|
5
N/A
|
(12)
N/A
|
(21)
-70%
|
(15)
+29%
|
(7)
+56%
|
19
N/A
|
20
+6%
|
(27)
N/A
|
(46)
-72%
|
(71)
-54%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
4
|
4
|
4
|
4
|
4
|
3
|
0
|
3
|
4
|
5
|
2
|
0
|
(0)
|
(1)
|
0
|
1
|
1
|
|
Income from Continuing Operations |
(12)
|
(11)
|
(12)
|
(10)
|
(9)
|
(9)
|
(13)
|
(18)
|
(18)
|
(15)
|
(7)
|
(10)
|
(9)
|
(4)
|
(6)
|
(10)
|
(16)
|
(13)
|
(9)
|
(9)
|
(10)
|
(11)
|
(10)
|
(9)
|
(10)
|
(13)
|
(16)
|
(17)
|
(11)
|
(9)
|
(0)
|
8
|
(8)
|
(16)
|
(13)
|
(6)
|
19
|
19
|
(27)
|
(45)
|
(70)
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
6
|
9
|
|
Net Income (Common) |
(12)
N/A
|
(11)
+10%
|
(12)
-10%
|
(10)
+11%
|
(9)
+16%
|
(9)
-3%
|
(13)
-41%
|
(18)
-38%
|
(18)
-3%
|
(15)
+16%
|
(7)
+53%
|
(10)
-40%
|
(9)
+6%
|
(4)
+63%
|
(6)
-66%
|
(10)
-76%
|
(16)
-51%
|
(13)
+19%
|
(9)
+25%
|
(9)
+8%
|
(10)
-10%
|
(11)
-15%
|
(10)
+10%
|
(9)
+14%
|
(10)
-15%
|
(13)
-30%
|
(16)
-25%
|
(17)
-2%
|
(11)
+36%
|
(9)
+15%
|
(0)
+95%
|
8
N/A
|
(8)
N/A
|
(16)
-106%
|
(13)
+22%
|
(6)
+50%
|
19
N/A
|
19
+3%
|
(25)
N/A
|
(39)
-60%
|
(62)
-57%
|
|
EPS (Diluted) |
-1.52
N/A
|
-1.79
-18%
|
-1.49
+17%
|
-1.32
+11%
|
-1.11
+16%
|
-1.13
-2%
|
-1.21
-7%
|
-1.67
-38%
|
-1.65
+1%
|
-1.35
+18%
|
-0.64
+53%
|
-0.89
-39%
|
-0.84
+6%
|
-0.31
+63%
|
-0.51
-65%
|
-0.9
-76%
|
-0.84
+7%
|
-0.68
+19%
|
-0.5
+26%
|
-0.32
+36%
|
-0.35
-9%
|
-0.39
-11%
|
-0.34
+13%
|
-0.21
+38%
|
-0.2
+5%
|
-0.25
-25%
|
-0.31
-24%
|
-0.3
+3%
|
-0.18
+40%
|
-0.15
+17%
|
-0.02
+87%
|
0.11
N/A
|
-0.11
N/A
|
-0.22
-100%
|
-0.16
+27%
|
-0.08
+50%
|
0.22
N/A
|
0.22
N/A
|
-0.26
N/A
|
-0.41
-58%
|
-0.64
-56%
|